By Michael Bloom
Publication Date: 2026-06-15 12:15:00
Here are Monday’s biggest calls on Wall Street: Morgan Stanley initiates Onto Innovation as overweight The firm said the semis company has upside to consensus. “We think there is upside to street estimates as well as scope for multiple re-rating for ONTO, a process control SPE [special purpose entity] company involved in both the back-end and front-end, driven by three drivers…” Needham initiates Ceva as buy Needham said the IP solutions for the semis industry is an AI beneficiary. “We are launching coverage of CEVA, Inc. (ticker: CEVA) with a Buy rating and a price target of $55, equal to 70x P/E on our CY27 EPS estimate.” UBS initiates Jade Biosciences as buy UBS said the biotech company has best-in-class potential. “We also think the FDA is becoming more amenable to accepting shorter i.e.,12- month eGFR kidney function data for full approval too which should help JADE to accelerate enrollment of their pivotal study.” JPMorgan initiates Esco Technologies as overweight JPMorgan said the industrial company has a differentiated offering. “We initiate coverage of ESCO Technologies (E SE) with an Overweight rating and a Dec. 2027 price target of $420, implying ~33% upside potential from current levels.” Baird names Capital One a fresh pick Baird said the stock has a slew of positive catalysts ahead. “From our perspective, COF shares represent one of the best ideas in our coverage, as market participants remain focused on narratives around a potentially weak consumer,…
